Stock analysis, price data, and AI-powered insights for Biogen (BIIB).
Biogen operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for BIIB.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). BIIB Stock Intelligence Report. [stoxpulse.com/stocks/biib]
Disclaimer: The information on this page about Biogen (BIIB) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Biogen.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 20%
Jun 30
Minor sold 593 shares
Aug 4
Minor sold 593 shares
Aug 3
Biogen Sees Pivotal Pipeline Moment as It Expands ...
1d ago
Thursday's session: top gainers and losers in the ...
3d ago
StoxPulse AI results for BIIB: Pulse Score 50/100. Primary sentiment trends from 7 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$32.08B
P/E Ratio
20.0
EPS
$-0.33
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sep 25
+21.5%
Dec 25
+20.9%
Mar 26
+26.3%
Jun 26
+19.8%
Beat estimates 4 of 4 quarters (100%)
Sector
Healthcare
Industry
Biotechnology
Biogen Sees Pivotal Pipeline Moment as It Expands Beyond Neurology
Thursday's session: top gainers and losers in the S&P500 index
HSBC Maintains Reduce on Biogen, Raises Price Target to $175
Biogen Inc. (BIIB) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Biogen CEO: We are at that inflection point where we are on a path to sustainable revenue growth
Register Now: Limited Seating Remains for HMG Strategy’s Sept. 10 Boston C-Level Technology Leadership Summit
Lilly Builds Neuroscience into a New Long-Term Growth Driver